|
AMD
|
Technology |
Melius Research |
Upgrade
|
Hold
→
Buy
|
—
|
$732.2B
|
$138.58
|
+1.3%
|
+5.5%
|
+2.1%
|
-0.5%
|
-0.4%
|
-1.0%
|
|
V
|
Financial Services |
KeyBanc Capital Markets |
Maintains
|
Overweight
→
Overweight
|
—
|
$648.6B
|
$259.69
|
+0.5%
|
+1.1%
|
+0.3%
|
+0.5%
|
-0.2%
|
+0.1%
|
|
CSCO
|
Technology |
Melius Research |
Downgrade
|
Buy
→
Hold
|
—
|
$461.3B
|
$50.09
|
-0.7%
|
+0.7%
|
-1.1%
|
+0.7%
|
+0.4%
|
-0.2%
|
|
MA
|
Financial Services |
KeyBanc Capital Markets |
Maintains
|
Overweight
→
Overweight
|
—
|
$448.7B
|
$419.42
|
+0.0%
|
+0.6%
|
+0.1%
|
+1.3%
|
-0.4%
|
+0.6%
|
|
MA
|
Financial Services |
Jefferies |
Maintains
|
Buy
→
Buy
|
—
|
$448.7B
|
$419.42
|
+0.0%
|
+0.6%
|
+0.1%
|
+1.3%
|
-0.4%
|
+0.6%
|
|
CVX
|
Energy |
JefferiesA+ |
Upgrade
|
Hold
→
Buy
|
—
|
$366.1B
|
$150.40
|
-1.3%
|
-0.6%
|
-2.5%
|
-0.8%
|
+0.5%
|
+1.4%
|
|
WFC
|
Financial Services |
Baird |
Downgrade
|
Outperform
→
Neutral
|
—
|
$239.9B
|
$49.92
|
-1.1%
|
+0.0%
|
-1.3%
|
-0.4%
|
-0.1%
|
-3.3%
|
|
AXP
|
Financial Services |
Baird |
Downgrade
|
Neutral
→
Underperform
|
—
|
$215.6B
|
$189.06
|
-0.4%
|
+0.1%
|
-1.3%
|
-1.0%
|
+0.0%
|
-1.6%
|
|
ANET
|
Technology |
Melius Research |
Upgrade
|
Hold
→
Buy
|
—
|
$179.2B
|
$57.73
|
+1.8%
|
+6.5%
|
-0.3%
|
+1.6%
|
+1.0%
|
+0.1%
|
|
TMO
|
Healthcare |
Bernstein |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$168.8B
|
$531.23
|
-0.3%
|
+1.9%
|
+0.1%
|
+0.4%
|
+0.4%
|
-0.3%
|
|
SCHW
|
Financial Services |
Raymond James |
Maintains
|
Outperform
→
Outperform
|
—
|
$163.1B
|
$67.23
|
-0.3%
|
+0.8%
|
-1.5%
|
-1.4%
|
-0.9%
|
-0.0%
|
|
DELL
|
Technology |
JP MorganA |
Upgrade
|
Neutral
→
Overweight
|
—
|
$160.9B
|
$75.84
|
+2.8%
|
+4.6%
|
-2.8%
|
+1.5%
|
+1.9%
|
-0.5%
|
|
DE
|
Industrials |
Melius Research |
Downgrade
|
Buy
→
Hold
|
—
|
$151.6B
|
$395.96
|
-0.6%
|
+0.5%
|
-1.2%
|
+0.1%
|
-0.9%
|
-1.0%
|
|
CB
|
Financial Services |
Goldman Sachs |
Downgrade
|
Buy
→
Neutral
|
—
|
$130.2B
|
$227.70
|
-0.0%
|
-0.7%
|
-0.4%
|
-0.0%
|
+1.1%
|
-0.1%
|
|
BP
|
Energy |
Piper Sandler |
Downgrade
|
Overweight
→
Neutral
|
—
|
$119.7B
|
$36.03
|
-1.8%
|
-1.7%
|
-1.5%
|
-0.5%
|
-0.3%
|
+0.7%
|
|
CME
|
Financial Services |
Barclays |
Downgrade
|
Overweight
→
Equal Weight
|
—
|
$108.9B
|
$199.19
|
-0.2%
|
+0.5%
|
-1.5%
|
+0.4%
|
-0.7%
|
+0.6%
|
|
COF
|
Financial Services |
Baird |
Downgrade
|
Outperform
→
Neutral
|
—
|
$98.5B
|
$132.42
|
-0.7%
|
+1.0%
|
-0.6%
|
-3.0%
|
-0.5%
|
-0.5%
|
|
FDX
|
Industrials |
Melius Research |
Upgrade
|
Hold
→
Buy
|
—
|
$91.1B
|
$246.81
|
+0.6%
|
+0.7%
|
-0.5%
|
+1.4%
|
+0.0%
|
-0.9%
|
|
ICE
|
Financial Services |
BarclaysB |
Upgrade
|
Equal Weight
→
Overweight
|
—
|
$89.1B
|
$125.79
|
+1.1%
|
+2.1%
|
-1.1%
|
+0.5%
|
-0.7%
|
+0.1%
|
|
CSX
|
Industrials |
SusquehannaC |
Upgrade
|
Neutral
→
Positive
|
—
|
$85.9B
|
$34.62
|
+0.3%
|
+0.2%
|
-0.2%
|
+0.3%
|
-0.4%
|
+0.8%
|